lansoprazole has been researched along with Renal Insufficiency, Chronic in 4 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, S | 1 |
| Zhao, J | 1 |
| Chen, X | 1 |
| Xu, S | 1 |
| Yang, X | 1 |
| Zhang, Y | 1 |
| Ma, Z | 1 |
| Jiang, H | 1 |
| Zhou, H | 1 |
| Arita, Y | 1 |
| Nakayama, M | 1 |
| Matsukuma, Y | 1 |
| Yoshitomi, R | 1 |
| Seki, M | 1 |
| Fukui, A | 1 |
| Tsuda, S | 1 |
| Sonoda, Y | 1 |
| Imazu, R | 1 |
| Arakawa, K | 1 |
| Tominaga, M | 1 |
| Nakano, T | 1 |
| Tsuruya, K | 1 |
| Kitazono, T | 1 |
| Park, Y | 1 |
| Jung, JM | 1 |
| Tantry, US | 1 |
| Kim, K | 1 |
| Koh, JS | 1 |
| Park, JR | 1 |
| Hwang, SJ | 1 |
| Kwak, CH | 1 |
| Hwang, JY | 1 |
| Kim, S | 1 |
| Gurbel, PA | 1 |
| Jeong, YH | 1 |
| Mikolasevic, I | 1 |
| Milic, S | 1 |
| Stimac, D | 1 |
| Zaputovic, L | 1 |
| Lukenda Zanko, V | 1 |
| Gulin, T | 1 |
| Jakopcic, I | 1 |
| Klaric, D | 1 |
| Gulin, M | 1 |
| Orlic, L | 1 |
1 trial available for lansoprazole and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study.
Topics: Cardiovascular Diseases; Cilostazol; Clopidogrel; Female; Follow-Up Studies; Humans; Lansoprazole; M | 2014 |
3 other studies available for lansoprazole and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
Topics: Animals; Cytochrome P-450 CYP2E1; Indican; Lansoprazole; Mice; Omeprazole; Pantoprazole; Proteolysis | 2022 |
Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aortic Valve; Aortic Valve Stenosis; Calcinosi | 2020 |
Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Topics: Aged; Aged, 80 and over; Blood Pressure; Croatia; Female; Humans; Lansoprazole; Logistic Models; Mag | 2016 |